Global Medtech Mergers and Acquisitions (M&As) Analysis Report 2021: Robotic Surgical Innovations Witness a Huge Surge & Increased Acquisitions to Enhance Connected Care Capabilities

News provided by

Dec 14, 2021, 18:15 ET

DUBLIN, Dec. 14, 2021 /PRNewswire/ -- The "Global Medtech Mergers and Acquisitions (M&As) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

This study examines the different mergers and acquisitions in the medtech industry, analyses the trends driving them, and identifies the growth opportunities for the next few years.

The healthcare industry has been adapting to changes induced by the COVID-19 pandemic. Medtech, for its part, has been pursuing mergers and acquisitions (M&As) to implement reforms and help the industry recover.

Companies in the traditional clinical segments in medtech, such as orthopedics, cardiology, ear, nose, and throat (ENT), wound care, urology, and respiratory care, registered several notable acquisitions and signed a number of deals with companies in emerging segments like women's health, connectivity solutions, home-based care, infection prevention, patient monitoring, and integrated operating room (OR).

Acquisitions have become the preferred way for companies to include new technologies, capabilities, or solutions to their existing product portfolios.

Some companies made acquisitions to expand their presence in different regions or segments. The impact of the COVID-19 pandemic led some companies that were struggling to reduce debt or recover losses to make certain divestitures.

Several companies also made divestitures to focus on the company's organic growth or invest in robotic surgery, a key disruptive technology.

Key Topics Covered:

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative
The Impact of the Top 3 Strategic Imperatives on Medtech Mergers and Acquisitions (M&As)
Growth Opportunities Fuel the Growth Pipeline Engine

Growth Opportunity Analysis - Medtech M&As

Scope of Analysis
Global M&As Segmentation
Important Definitions
Growth Drivers for Medtech M&As
Growth Restraints for Medtech M&As
How is the Medtech Industry Evolving with M&As?
Global Medtech M&As Scenario Analysis
Tidal Wave of Merger Filings - Overwhelmed FTC Announces That it May Challenge Some Mergers Later

Medtech Mergers & Acquisitions

Number of Acquisitions and Deal Sizes Between January 2019 and August 2021
Acquisitions by Medtech Segments
Deals Investment Amount from Medtech Acquisitions
Reasons for Medtech Acquisitions
Medtech Acquisitions Deal Analysis
Top 5 Trends in Medtech Investments - Acquisitions
Impact of Acquisitions on the Ecosystem

Medtech Divestitures

Number of Divestitures and Deal Sizes
Divestitures Number by Segments
Divestitures by Deal Size and Segments
Reasons for Medtech Divestitures
Medtech Divestitures Deal Analysis
Top 5 Trends in Medtech Investments - Divestitures

Profiling of Top 5 Medtech Deals

Baxter Acquires Hill-Rom to Integrate Connected Care with its Existing Portfolio of Dialysis Technology and Infusion Pumps
STERIS Acquires Cantel to Enhance its Infection Prevention Portfolio, and J&J Divests its ASP to Fortive Corporation to Focus on its Organic Growth
3M Acquires Acelity to Strengthen its Advanced Wound Care Position, and Siemens Healthineers Acquires Varian Medical to Provide All-comprehensive Cancer Care

Growth Opportunity Universe

Growth Opportunity 1: Robotic Surgical Innovations Witness a Huge Surge, 2020
Growth Opportunity 2: Increased Acquisitions to Enhance Connected Care Capabilities, 2020
Growth Opportunity 3: Pandemic-induced Transformation in the Medtech Industry Accelerates the Innovation and Adoption of Digital Solutions, 2020

For more information about this report visit https://www.researchandmarkets.com/r/wdbwvh

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets